P.027 Utilisation of livers donated after circulatory death (DCD) for transplantation – a large cohort study evaluating pre-retrieval biochemical characteristics and transplant outcomes
Dr. Syed Hussain Abbas, United Kingdom
P.071 Application of Hisense CAS to assess donor liver volume for living donor and split liver transplantation
Dr. Feng Wang, People's Republic of China
P.193 The interplay of donor-recipient relationship and donor race in living liver donation in the United States
Dr. Fawaz Al Ammary, United States
P.292 Using artificial neural networks to determine the quality of a liver transplant
Ms. Ekaterina Yu Anosova, Russian Federation
P.345 Biliary sludge and complications in multivisceral transplantation patients
Prof. Carmelo Loinaz, Spain
P.346 Influential factors in long-term quality of life after liver transplantation: More than 15 years of experience
Prof. Carmelo Loinaz, Spain
P.349 TIPS experience in variceal bleeding of patients on the liver transplantation waiting list in our center
Dr. Nomingerel Tseveldorj, Turkey
P.350 Psychosocial factors and immune tolerance in liver transplant recipients: insights from a cohort study
Dr. Seyed Ali Moosavi, Iran
P.351 Contrast-enhanced ultrasound assessment of arterial-portal arrival interval: Implications for post-transplant portal vein stenosis
Dr. Kyowon Gu, Korea
P.352 Recombinant growth hormone treatment in two patients with progressive familial intrahepatic cholestasis
Nur Berna Çelik Ertaş, Turkey
P.353 Impact factors leading to renal impairment after liver transplantation: a single center consecutive 12 years’ experience
Mr. Batsaikhan Batsuuri, Mongolia
P.354 Comparative analysis with or without external biliary drainage of the bile ducts during transplantation of the right lobe of the liver from a living donor
Dr. Serik Turebaevich Tileuov, Kazakhstan
P.355 Cortical ribbon sign in a liver transplant recipient with hepatic encephalopathy
Dr. Fatma Irem Yesiler, Turkey
P.356 Effectiveness of therapeutic plasma exchange following early postoperative liver transplantation in critical care unit
Dr. Fatma Irem Yesiler, Turkey
P.357 The effects of early postoperative thrombocytopenia at intensive care unit admission to allograft function and outcomes after liver transplantation
Dr. Pinar Zeyneloglu, Turkey
P.358 A rare presentation of Posttransplant Lymphoproliferative Disease (PTLD) in a pediatric liver transplantation patient: Plasmablastic lymphoma complicated with hemophagocytic lymphohistiocytosis
Dr. F. Burcu Belen Apak, Turkey
P.361 When is the best time to perform bariatric surgery in patients with liver transplantation and obesity? initial experience in a small hospital center
Dr. Ernesto Duarte Tagles, Mexico
P.364 Increased psychosocial risk factors in pediatric liver transplant patients transplanted for fulminant liver failure
Dr. Priya Walabh, South Africa
P.365 Is preoperative weight reduction of living-donor liver transplant recipients and donors harmful to postoperative outcomes?
Dr. Shohei Yoshiya, Japan
P.367 Outcomes of liver transplantation: A single-center experience. (First Central Hospital of Mongolia)
Dr. Bat-Ireedui Badarch, Mongolia
P.368 Management of arterial complications following living donor liver transplant
Dr. Konstantin Semash, Uzbekistan
P.369 Results of first 40 cases of living donor liver transplantation performed in Republic of Uzbekistan
Dr. Konstantin Semash, Uzbekistan
P.370 Correction of portal vein stenosis in patients following living donor liver transplantation
Dr. Konstantin Semash, Uzbekistan
P.371 Outcomes of living donor liver transplantation for hepatocellular carcinoma associated with benign versus malignant portal vein thrombosis.
Mr. Nafady M Ramy, United Kingdom
P.373 Analysis of the relationship between the MELD Scores and intraoperative LRRBC consumption in LDLT surgery at First Central Hospital of Mongolia
Odonchimeg Gombosuren, Mongolia
P.374 Domino cross auxiliary liver transplantation with whole graft for familial hypercholesterolemia in children
Dr. Adnan Torgay, Turkey
P.375 Living donor liver transplantation in biliary atresia with a portal vein less than two millimeters in diameter
Prof. Sedat Yildirim, Turkey
P.376 Accuracy between estimated graft volume and actual graft weight in living donor liver transplant
Dr. Mehmet Coskun, Turkey
P.377 Long-term quality of life and adherence status of patients with hepatocellular carcinoma after liver transplantation
Yaprak Sarigöl Ordin, Turkey
P.378 Association between pre- and post-transplant nutritional indices and skeletal muscle mass with 5-year survival after liver transplantation: a retrospective study
Ms. Ya-Tzu Tsao, Taiwan
P.379 New abstract created on Friday April 5, 2024
Biliary complications incidence, risks and outcome after liver transplantation : low volume single center experience
Dr. Jamilya Saparbay, Kazakhstan
P.382 Sonographic evaluation of spleen size, portal vein diameter, and laboratory test values after orthotropic liver transplantation
Dr. Mohsen Aliakbarian, Iran
P.385 From a little young lady to a grandmother: Thanks to liver transplantation
Prof. Sedat Yildirim, Turkey
P.386 Long-term outcomes of liver transplantation from elderly donors
Dr. Adnan Torgay, Turkey
P.387 Outcomes of Pediatric Hepatocellular Carcinoma: A Single-Center Experience with Resection vs Transplantation
Paula Medio Torrubiano, Spain
P.388 The indication of liver transplantation for hepatocellular carcinoma in post-direct acting antivirals era in Japan
Dr. Ryoichi Goto, Japan
P.389 No difference in recurrent hepatocellular carcinoma rates in liver transplanted patients receiving mTOR inhibitors compared to non-mTOR group
Dr. Anar Ganbold, Mongolia
P.393 Tacrolimus-related neurotoxicity in liver transplant – Is it safe to revert to tacrolimus from cyclosporine?
Dr. Utpala Uday, India
P.395 Management of liver transplant patients with recurrence of hepatocellular carcinoma
Fatih Boyvat, Turkey
P.396 The optimum level of MELD to minimize the mortality on liver transplantation waiting list and liver transplanted patient in Sao Paulo state Brazil
Prof. Eleazar Chaib Sr., Brazil
P.397 Optimal coagulation management in liver transplantation by point-of-care analysis using TEG6s in Japan
Muneyuki Matsumura, Japan
P.398 Evaluating Post-Liver Transplantation Outcomes in Hepatorenal Syndrome: Insights from a Small Volume Center Study
Dr. Yeon Ho Park, Korea
P.399 From ascites to rejection: Further recognizing antibody mediated rejection in pediatric living donor liver transplantation through case reports
Dr. Kai Wang, People's Republic of China
P.400 Assessing the efficacy of donor-derived cell-free DNA measurement in liver transplant recipients for rejection diagnosis and therapeutic response evaluation: A case report
P.402 The role of complement C4 and Alt level for acute rejection after liver transplantation
Dr. Batsaikhan Bat-Erdene, Mongolia
P.403 Donor-recipient lymphocyte turnover kinetics is affected by immunosuppressive treatment in a model of intestinal transplantation acute cellular rejection
Miss Ivana Ivanoff Marinoff, Argentina
P.404 Portal Inflow Modulation in Pediatric Partial Liver Transplantation: Insights from a Prospective Study
Dr. Artem R. Monakhov, Russian Federation
P.405 Comparison of the safety between modified right lobe graft and extended left lobe graft in small-for-size graft
Prof. Ho Joong Choi, Korea
P.406 Does tying first during hepatic artery reconstruction help prevent stenosis?
Prof. Kyeong Sik Kim, Korea
P.407 Comparison of pure laparoscopic donor left hepatectomy and pure laparoscopic donor right hepatectomy in the laparoscopic era
Prof. Ho Joong Choi, Korea
P.409 Surgical treatment of Portal Hypertension. Analysis of 116 consecutive cases.
Aydin Dalgic, Turkey
P.410 Using double J stent in liver transplant to prevent bile leak
Dr. Emre Karakaya, Turkey
P.411 Percutaneous management of portal vein stenosis after liver transplantation
Fatih Boyvat, Turkey
P.412 Detection of early postoperative active bleeding after liver transplantation using 384-slice CT angiography
Dr. Burak Yagdiran, Turkey
P.413 Mass cytometry and single cell RNA sequencing analysis of mouse liver transplantation
Dr. Masayuki Fujino, Japan
P.414 Small but Safe: Initial Experience of Liver Transplantation at Single Center
Dr. Chang Ho Seo, Korea
P.415 Tobacco influence on short-term outcomes of liver transplantation
Mrs. Alba Gomez Barrena, Spain
P.416 Comparative study between liver transplant recipients older and younger than 70 years. A call for caution
Mrs. Alba Gomez Barrena, Spain
P.417 Free microvascular tissue transfers in solid organ transplant candidates and recipients